Latest News
|
25 March 2013
0 Likes 
A warning issued by the European Medicines Agency (EMA) on 22 March 2013 cautions healthcare providers and the public not to use cilostazol-containing medicines to treat intermittent claudication, a
Read More...
Latest News
|
18 March 2013
0 Likes
The European Medicines Agency (EMA) has announced that it has simplified the process by which marketing authorization applications (MAAs) are submitted to the agency, reducing the number of
Read More...
Latest News
|
19 December 2012
0 Likes
The European Medicines Agency (EMA) is preparing to reorganize its operations, processes and offices in 2013, it has announced.In a statement released on its website on 19 December 2012, the agency
Read More...
Latest News
|
22 October 2012
0 Likes
The European Medicines Agency (EMA) has appointed Ian Hudson as the new vice-chair of its Committee for Medicinal Products for Human Use (CHMP) after its previous vice-chair was appointed to the
Read More...
Latest News
|
2 October 2012
0 Likes
A new concept paper released by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) seeks to establish an updated framework for anti-obesity and weight control drug
Read More...
Latest News
|
17 September 2012
0 Likes
The European Medicines Agency (EMA), currently in the midst of a number of changes in committee staff, has elected Thomas Salmonson as the new chair of its influential Committee for Medicinal Products
Read More...
Latest News
|
20 July 2012
0 Likes
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended for use the first gene therpy product in the European Union, regulators said Friday, 20
Read More...
Latest News
|
25 May 2012
0 Likes
The European Medicines Agency (EMA) has recommended Vertex Pharmaceuticals' cystic fibrosis (CF) drug Kalydeco (ivacaftor), moving the drug one step closer to becoming the drug the first in Europe for
Read More...
Latest News
|
4 May 2012
0 Likes
The European Medicines Agency (EMA) announced 5 May it has adopted a scientific guideline on aspects relating to the development and testing of medicinal products containing genetically modified
Read More...
Regulatory Update
|
17 April 2012
0 Likes
The European Medicines Agency (EMA) yesterday (16 April) published guidance, in the form of a final reflection paper, on ethical and good clinical practice (GCP) aspects of clinical trials conducted
Read More...